Centene (NYSE:CNC – Get Free Report) and Chartwell Retirement Residences (OTCMKTS:CWSRF – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.
Insider & Institutional Ownership
93.6% of Centene shares are owned by institutional investors. Comparatively, 37.8% of Chartwell Retirement Residences shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Centene and Chartwell Retirement Residences, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Centene | 2 | 10 | 7 | 1 | 2.35 |
| Chartwell Retirement Residences | 0 | 0 | 5 | 0 | 3.00 |
Profitability
This table compares Centene and Chartwell Retirement Residences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Centene | -2.51% | 12.12% | 3.20% |
| Chartwell Retirement Residences | N/A | N/A | N/A |
Valuation and Earnings
This table compares Centene and Chartwell Retirement Residences”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Centene | $194.78 billion | 0.17 | -$6.67 billion | ($10.44) | -6.29 |
| Chartwell Retirement Residences | N/A | N/A | N/A | ($0.03) | -551.54 |
Chartwell Retirement Residences has lower revenue, but higher earnings than Centene. Chartwell Retirement Residences is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.
Summary
Centene beats Chartwell Retirement Residences on 9 of the 12 factors compared between the two stocks.
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
About Chartwell Retirement Residences
Chartwell is in the business of serving and caring for Canada’s seniors, committed to its vision of Making People’s Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents. Chartwell is an unincorporated, open-ended real estate trust which indirectly owns and operates a complete range of seniors housing communities, from independent living through to assisted living and long term care. Chartwell is the largest operator in Canada, serving over 25,000 residents in four provinces across the country.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
